Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

University of Kansas Cancer Center, Kansas City, Kansas

University of Michigan Rogel Cancer Center, Ann Arbor, Michigan

Ohio State University Comprehensive Cancer Center, Columbus, Ohio